Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:A PM Leaves M.D. Sass, and His Fund Follows Not Rated 4.0 Email Routing List Email & Route  Print Print
Tuesday, July 3, 2012

A PM Leaves M.D. Sass, and His Fund Follows

Reported by Chris Cumming

Aston Asset Management has switched subadvisors for one of its alternatives funds. But it is not switching PMs.

The Chicago-based mutual fund shop has given Anchor Capital Management the sub-advisory contract formerly held by M.D. Sass, and so the ASTON/M.D. Sass Enhanced Equity Fund will become the ASTON/Anchor Capital Enhanced Equity Fund. [SEC filing.]

But the fund's management will remain in place, because Anchor hired Ron Altman away from M.D. Sass, and Aston's trustees have decided to stick with their man.

Altman has PMed the fund since its inception.

Anchor CEO Bill Rice told MFWire that Altman's trader, Adam Neves, will also be joining Anchor. Neves was most recently at Collins Stewart LLC.

There is a press release on the switch available for download on Aston's website.

Rice told MFWire that this Aston-sponsored, co-branded fund invests in large/mid-cap high-yield securities, and uses puts and calls. It has $141 million in AUM, and holds a four star rating from Morningstar

Correction: An earlier version of this story incorrectly reported that Adam Neves joined Anchor from M.D. Sass. Neves was most recently at Collins Stewart LLC and was never employed by M.D. Sass.

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

4.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2025: Q4Q3Q2Q1
2024: Q4Q3Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly


  1. MFDF webinar - AI and Third-Party Oversight, November 10
  2. 2025 Nicsa Asset & Wealth Management Summit, Nov 11-12
  3. IDC Director Segment Meeting - Directors of Alternative Investment Products, November 11
  4. IMEA webinar - The Evolving RIA Marketplace & Increasing Use of Active ETFs, November 12
  5. ALFI Roadshow to Miami, November 12
  6. MFDF webinar - Mutual Fund CCO Compensations: The MPI Annual Survey Update, November 13
  7. ALFI Roadshow to Houston, November 13
  8. 2025 Expect Miracles In Boston Gala, November 13
  9. WE Washington DC - Fall Happy Hour, November 13
  10. 2025 MMI Legal & Compliance Virtual Forum, November 13
  11. Citywire Private Assets Retreat 2025, Nov 13-14
  12. IMEA Institutional Roundtable, November 18
  13. WE South - Offshore 360: the Macro View, November 19
  14. IDC Director Segment Meeting - Directors at Small Fund Complexes, November 19
  15. Nicsa ETF Share Classes Operational Considerations, November 19
  16. MFDF webinar - ETF Dual-Class Relief Impacts on Board Oversight, November 19
  17. ICI Retail Alternatives and Closed-End Funds Conference, November 20
  18. ICI Securities Law Developments Conference, November 20
  19. MFDF webinar - Essential Strategies in Board Oversight of AI, Cybersecurity, and Emerging Technology Risks, December 1
  20. MFDF In Focus - Gartenberg Factors, December 2
  21. MFDF webinar - Digital Assets Regulatory Updates & Trends in the Industry, December 3
  22. MFDF webinar - Fixed Income Insights: Navigating Market Trends & Opportunities, December 9
  23. MFDF webinar - Navigating Co-Investment Relief for Fund Boards, December 16
  24. MFDF webinar - 2025 Fair Valuation Pricing Survey Update, December 18
  25. MFDF 2026 Directors' Institute, January 26 - 28, 2026
  26. MFDF 2026 Fund Governance & Regulatory Insights Conference, March 5 - 6, 2026




©All rights reserved to InvestmentWires, Inc. 1997-2025
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use